D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 58 Citations 11,415 294 World Ranking 2307 National Ranking 10

Overview

What is she best known for?

The fields of study she is best known for:

  • Acquired immunodeficiency syndrome
  • Internal medicine
  • Disease

Immunology, Acquired immunodeficiency syndrome, Virology, Internal medicine and Pediatrics are her primary areas of study. Her study focuses on the intersection of Immunology and fields such as Transmission with connections in the field of Reverse-transcriptase inhibitor. Glenda Gray interconnects Psychological intervention and Socioeconomic status in the investigation of issues within Acquired immunodeficiency syndrome.

Her work on Lentivirus as part of general Virology research is often related to Ctl epitope, thus linking different fields of science. The various areas that Glenda Gray examines in her Internal medicine study include Placebo and Oncology. The concepts of her Clinical trial study are interwoven with issues in HIV vaccine and Tolerability.

Her most cited work include:

  • Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. (447 citations)
  • Prevalence and Patterns of Gender-based Violence and Revictimization among Women Attending Antenatal Clinics in Soweto, South Africa (251 citations)
  • Emergence of Drug-Resistant HIV-1 after Intrapartum Administration of Single-Dose Nevirapine Is Substantially Underestimated (213 citations)

What are the main themes of her work throughout her whole career to date?

Glenda Gray mostly deals with Immunology, Acquired immunodeficiency syndrome, Internal medicine, Virology and HIV vaccine. Her Immunology study which covers Transmission that intersects with Pediatrics, Intervention and Drug resistance. As part of the same scientific family, Glenda Gray usually focuses on Acquired immunodeficiency syndrome, concentrating on Psychological intervention and intersecting with Young adult and Reproductive health.

Her work carried out in the field of Internal medicine brings together such families of science as Cross-sectional study and Placebo. Glenda Gray works in the field of Virology, namely Virus. Her HIV vaccine research includes themes of Clinical trial, Family medicine, Vaccine efficacy, Vaccination and MF59.

She most often published in these fields:

  • Immunology (27.29%)
  • Acquired immunodeficiency syndrome (20.53%)
  • Internal medicine (21.98%)

What were the highlights of her more recent work (between 2018-2021)?

  • HIV vaccine (21.50%)
  • Internal medicine (21.98%)
  • Young adult (15.46%)

In recent papers she was focusing on the following fields of study:

Her primary areas of study are HIV vaccine, Internal medicine, Young adult, Vaccination and Family medicine. Her HIV vaccine study also includes fields such as

  • Immunology together with Trichomonas vaginalis,
  • Regimen which is related to area like Gastroenterology. Her work in Internal medicine is not limited to one particular discipline; it also encompasses Cross-sectional study.

In her research, Interpersonal relationship is intimately related to Reproductive health, which falls under the overarching field of Young adult. Her Family medicine research is multidisciplinary, incorporating elements of Psychological intervention, Condom and Partner notification. Her Antibody study combines topics from a wide range of disciplines, such as Clinical trial and Virology.

Between 2018 and 2021, her most popular works were:

  • COVID-19 in Africa: care and protection for frontline healthcare workers. (85 citations)
  • Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19. (19 citations)
  • The Complex Challenges of HIV Vaccine Development Require Renewed and Expanded Global Commitment (17 citations)

In her most recent research, the most cited papers focused on:

  • Acquired immunodeficiency syndrome
  • Internal medicine
  • Disease

Her primary scientific interests are in HIV vaccine, Vaccination, Immunology, Antibody and Virology. She has included themes like Public health, AIDS Vaccines, MEDLINE and Family medicine in her HIV vaccine study. Glenda Gray combines subjects such as Regimen, Economic evaluation, Incidence and Environmental health with her study of Vaccination.

Her Regimen study integrates concerns from other disciplines, such as Adverse effect, Placebo, Not evaluated and Randomized controlled trial. Her study connects Young adult and Immunology. Her research integrates issues of Multiplex, Canarypox, Epitope, Linear epitope and Immunogen in her study of Virology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.

C. Celum;A. Wald;A. Wald;J.R. Lingappa;A.S. Magaret;A.S. Magaret.
The New England Journal of Medicine (2010)

587 Citations

Prevalence and Patterns of Gender-based Violence and Revictimization among Women Attending Antenatal Clinics in Soweto, South Africa

Kristin L. Dunkle;Rachel K. Jewkes;Heather C. Brown;Mieko Yoshihama.
American Journal of Epidemiology (2004)

396 Citations

Community-based intervention to increase HIV testing and case detection in people aged 16–32 years in Tanzania, Zimbabwe, and Thailand (NIMH Project Accept, HPTN 043): a randomised study

Michael Sweat;Stephen Morin;David Celentano;Marta Mulawa.
Lancet Infectious Diseases (2011)

296 Citations

Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort.

Jonathan E Golub;Paul Pronyk;Paul Pronyk;Lerato Mohapi;Nkeko Thsabangu.
AIDS (2009)

294 Citations

International Seroepidemiology of Adenovirus Serotypes 5, 26, 35, and 48 in Pediatric and Adult Populations

Dan H. Barouch;Dan H. Barouch;Sandra V. Kik;Gerrit J. Weverling;Rebecca Dilan.
Vaccine (2011)

278 Citations

Emergence of Drug-Resistant HIV-1 after Intrapartum Administration of Single-Dose Nevirapine Is Substantially Underestimated

Jeffrey A. Johnson;Jin Fen Li;Lynn Morris;Neil Martinson.
The Journal of Infectious Diseases (2005)

263 Citations

Hierarchical Targeting of Subtype C Human Immunodeficiency Virus Type 1 Proteins by CD8+ T Cells: Correlation with Viral Load

Agatha Masemola;Tumelo Mashishi;Greg Khoury;Phineas Mohube.
Journal of Virology (2004)

255 Citations

Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)

Dan H Barouch;Dan H Barouch;Frank L Tomaka;Frank Wegmann;Daniel J Stieh.
The Lancet (2018)

226 Citations

The NEAT study: a 48-week open-label study to compare the antiviral efficacy and safety of GW433908 versus nelfinavir in antiretroviral therapy-naive HIV-1-infected patients.

Amalia Rodriguez-French;Jack Boghossian;Glenda E Gray;Jeffrey P Nadler.
Journal of Acquired Immune Deficiency Syndromes (2004)

205 Citations

Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial.

Jairam R Lingappa;Jared M Baeten;Anna Wald;James P Hughes.
The Lancet (2010)

198 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Glenda Gray

Connie Celum

Connie Celum

University of Washington

Publications: 103

Jared M. Baeten

Jared M. Baeten

University of Washington

Publications: 95

Linda-Gail Bekker

Linda-Gail Bekker

University of Cape Town

Publications: 86

Dan H. Barouch

Dan H. Barouch

Harvard Medical School

Publications: 84

Lynn Morris

Lynn Morris

University of the Witwatersrand

Publications: 79

Bruce D. Walker

Bruce D. Walker

Harvard University

Publications: 78

Peter B. Gilbert

Peter B. Gilbert

Fred Hutchinson Cancer Research Center

Publications: 64

Lawrence Corey

Lawrence Corey

Fred Hutchinson Cancer Research Center

Publications: 56

Anna Wald

Anna Wald

University of Washington

Publications: 55

Salim S. Abdool Karim

Salim S. Abdool Karim

Centre for the AIDS Programme of Research in South Africa

Publications: 53

Philip J. R. Goulder

Philip J. R. Goulder

University of Oxford

Publications: 50

Elizabeth A. Bukusi

Elizabeth A. Bukusi

University of Washington

Publications: 49

Susan H. Eshleman

Susan H. Eshleman

Johns Hopkins University School of Medicine

Publications: 48

David C. Montefiori

David C. Montefiori

Duke University

Publications: 46

Anna-Lise Williamson

Anna-Lise Williamson

University of Cape Town

Publications: 45

Carolyn Williamson

Carolyn Williamson

University of Cape Town

Publications: 45

Trending Scientists

Iis P. Tussyadiah

Iis P. Tussyadiah

University of Surrey

Dong-Seok Hyun

Dong-Seok Hyun

Hanyang University

Yuguo Li

Yuguo Li

University of Hong Kong

Michael Adams

Michael Adams

University of Birmingham

Paul Ratnasamy

Paul Ratnasamy

University of Louisville

Thorsten Reemtsma

Thorsten Reemtsma

Technical University of Berlin

S. P. Armes

S. P. Armes

University of Sheffield

Leon A. Barmuta

Leon A. Barmuta

University of Tasmania

Jochen B. W. Wolf

Jochen B. W. Wolf

Ludwig-Maximilians-Universität München

Peter A. Rona

Peter A. Rona

Rutgers, The State University of New Jersey

Paul N. Williams

Paul N. Williams

Queen's University Belfast

Jukka Partanen

Jukka Partanen

Finnish Red Cross

Gianluca Esposito

Gianluca Esposito

University of Trento

James B. Weaver

James B. Weaver

Centers for Disease Control and Prevention

João Paulo Souza

João Paulo Souza

Universidade de São Paulo

B. Lundberg

B. Lundberg

Lund University

Something went wrong. Please try again later.